When will we see the First Oral Drug Approved?

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Medscape Article--Current and New Approaches in MS Therapies

Postby Shayk » Mon Sep 03, 2007 7:13 pm

All

Here's a link to an article from Medscape Current and New Approaches in MS Therapies that discusses several of the oral therapies in the pipeline (and others).

You may have to register first, but it's free. It's program 7687.

Sharon
User avatar
Shayk
Family Elder
 
Posts: 779
Joined: Fri Feb 06, 2004 4:00 pm

Advertisement

Postby CureOrBust » Wed Sep 26, 2007 1:59 am

DOH! Image

I followed up on my previous post with an email to Novartis to find out if the results from the completed Phase III trial in Renal transplant patients would result in FTY720 being commercially available before it is available after the current Phase III trial in MS. Below is the response I got back.

Renal transplantation Phase III results indicated that FTY720 in combination with cyclosporine provides no benefit over the current standard of care. Therefore, all clinical trials have been stopped. FTY720 is currently in Phase III trials to test is safety and efficacy in patients with relapsing-remitting multiple sclerosis.

Please let me know if you have any additional questions.
Best regards,
Julie Morrow, PhD
Global PR Manager, Neuroscience
User avatar
CureOrBust
Family Elder
 
Posts: 2914
Joined: Wed Jul 27, 2005 3:00 pm
Location: Sydney, Australia

Previous

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service